Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STSA | AZN | AMGN | GILD | VRTX |
| Company | Satsuma Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1100 | 91.00 | 318.39 | 121.35 | 444.49 |
| High | 1.1400 | 91.00 | 318.39 | 121.35 | 444.49 |
| Low | 1.0100 | 91.00 | 318.39 | 121.35 | 444.49 |
| Latest | 1.1000 | 91.00 | 318.39 | 121.35 | 444.49 |
| Change | -0.0100 | -0.51 | +3.01 | +0.01 | -0.15 |
| % Change | -0.90% | -0.56% | +0.95% | +0.01% | -0.03% |
| Volume | 1,829,700 | 71,363 | 1,386 | 2,195 | 346 |
| 20-Day Average Volume | 576,695 | 5,320,243 | 2,796,199 | 6,934,755 | 1,328,027 |
| Previous Close | 1.1100 | 91.51 | 315.38 | 121.34 | 444.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0658 | 90.57 | 335.00 | 124.36 | 436.69 |
| 20-Day Raw Stochastic | 69.23% | 52.85% | 16.15% | 25.94% | 57.28% |
| 20-Day Relative Strength | 58.87 | 58.99 | 48.14 | 48.77 | 56.53 |
| Weighted Alpha | -14.90 | +40.31 | +17.88 | +29.15 | -0.71 |
| Today's Opinion | 8% Buy | 100% Buy | 72% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 8% Buy | 100% Buy | 72% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 8% Sell | 100% Buy | 56% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.76% since 05/31/23 | +1.08% since 12/04/25 | -6.40% since 12/04/25 | -1.04% since 12/04/25 | -2.81% since 12/04/25 |
| Low | 1.0100 on 06/07/23 | 89.67 on 12/08/25 | 313.00 on 12/10/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 1.1400 on 06/07/23 | 91.66 on 12/10/25 | 340.88 on 12/05/25 | 122.53 on 12/05/25 | 462.00 on 12/05/25 |
| 1-Month | |||||
| %Chg | +2.80% since 05/05/23 | +2.14% since 11/11/25 | -5.93% since 11/11/25 | -0.99% since 11/11/25 | +3.56% since 11/11/25 |
| Low | 1.0100 on 06/07/23 | 87.23 on 11/12/25 | 313.00 on 12/10/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 1.1400 on 06/07/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +16.17% since 03/07/23 | +12.21% since 09/11/25 | +12.61% since 09/11/25 | +2.96% since 09/11/25 | +11.86% since 09/11/25 |
| Low | 0.6550 on 04/14/23 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.4700 on 04/17/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +31.28% since 12/07/22 | +23.41% since 06/11/25 | +9.11% since 06/11/25 | +11.02% since 06/11/25 | -1.76% since 06/11/25 |
| Low | 0.6550 on 04/14/23 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 1.4700 on 04/17/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 36,467 | 283,811,488 | 169,826,144 | 150,544,112 | 112,813,616 |
| Shares Outstanding, K | 33,152 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -70,060,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -10,290,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.10 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 05/11/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 08/08/23 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | 03/28/14 | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.65 | 14.35 | 14.57 | 28.54 |